Beraprost-[d3]

Labelled Beraprost. Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. Beraprost acts by binding to prostacyclin membrane receptors ultimately inhibiting the release of Ca2+ from intracellular storage sites. Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects.
Supplier BOC Sciences
Product # BLP-003439
Pricing Inquire
Molecular Weight 401.51
Molecular Formula C24H27O5D3
Canonical SMILES CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O
Feedback